#16
|
||||
|
||||
Íåò, ÿ ïðèñëóøàëàñü ê Âàì. Òîëüêî ïîäñêàæèòå 4 ÷àñà ãîëîäà äîñòàòî÷íî äëÿ ÎÀÊ?
|
#17
|
||||
|
||||
äà, äàæå åñëè ëåãêî ïîêóøàåò çà 1 ÷ - âñå ïðèåìëåìî; íàäåþñü - åòî ëÿï, âî èçáåæàíèå áåñïîêîéñòâà ñòàðàéòåñü íå äåëàòü òàê áîëüøå êðîâü, ïîêà íå èñïðàâÿò ðàìêó èëè ðàìùèêà
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#18
|
||||
|
||||
Ñïàñèáî 🙏 ñäàäèì çàâòðà è óâèäèì.
|
#19
|
||||
|
||||
Äîáðûé âå÷åð, ÎÀÊ ñäàëè ñåãîäíÿ, ïîëó÷èëè îòâåò. Ïðîêîììåíòèðóéòå ïîæàëóéñòà.
|
#20
|
||||
|
||||
äàííûé àíàëèç èäåàëüíûé è íå íà ÷òî íå óêàçûâàåò, áûòü ìîæåò ðåáåíêó àíòèáèîòèêè íå íóæíû
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#21
|
||||
|
||||
Íî ìû ñåé÷àñ ïüåì àíòèáèîòèê 4-âé ûé äåíü. Äóìàþ ïðèäåòñÿ äîïèòü 10 äíåé ÷òîáû íå âåðíóëèñü ñèìïòîìû. ß Âàì áëàãîäàðíà çà ïîìîùü. Íå ìîãëè áû âû ïîðåêîìåíäîâàòü òîëêîâîãî ïåäèàòðà â ÑÏá?
|
#22
|
||||
|
||||
ñëûøàë õîðîøåå òîëüêî ïðî ëàõòà êëèíèê êîâåíñêîå; åñëè íåò áàê. èíôåêöèè, òî àíòèáèîòèêè áîëüøå âðåäÿò, íåæåëè ïîìîãàþò
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
|
#23
|
||||
|
||||
Ïî ïîâîäó àíòèáèîòèêà. Ñåé÷àñ 4-ûé äåíü åãî ïðèíèìàåì. Ïîýòîìó è ëåéêîöèòû â íîðìå, íàñêîëüêî ÿ ïîíèìàþ.. Íî åñëè áàê èíôåêöèÿ áûëà, ñóäÿ ïî ïåðâîìó àíàëèçó, òî àíòèáèîòèêà íàäî ïîëíûé êóðñ ïðîïèòü?!
|
#24
|
||||
|
||||
ïåðâîìó àíàëèçó íåò äîâåðèÿ, âñå ïîäðîñòêè è âçðîñëûå ðåàãèðóþò ëåéêîöèòîçîì íà ëþáîå âîñïàëåíèå, âèð èëè áàê ïî àíàëèçó òîëüêî äëÿ äåòåé äî 5 ëåò è òî òî÷íîñòü êàê 30/70
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#25
|
||||
|
||||
Âû äóìàåòå ïðàâèëüíåå áóäåò çàêîí÷èòü ïðè¸ì àíòèáèîòèêà?
|
#26
|
||||
|
||||
ñ÷èòàþ, ÷òî 10 äíåé àìîêñèêëàâà èçáûòî÷íî, äàæå åñëè áû òàì áûë ñòðåïòîêîêê (äåëàåòñÿ ïðè àíãèíå ñïåö. àíàëèçîì!), òî
The efficacy of 3-day treatment with a combined clavulanate/amoxicillin preparation (Clavamox combination dry syrup for pediatric cases) and 10-day treatment with amoxicillin against pediatric pharyngolaryngitis and tonsillitis caused by Group A β-hemolytic Streptococcus was compared. Among the patients included in the efficacy evaluation (54 from the clavulanate/amoxicillin group and 43 from the amoxicillin group), the clinical response rate on completion of treatment was 98.1 % in the clavulanate/amoxicillin group and 92.9 % in the amoxicillin group, thus supporting the equivalent efficacy of these two therapies. --- J Infect Chemother. 2013 Feb;19(1):12-9. Comparison of clinical efficacy between 3-day combined clavulanate/amoxicillin preparation treatment and 10-day amoxicillin treatment in children with pharyngolaryngitis or tonsillitis èíôîðìàöèè 10 ëåò, òî åñòü ìîãëà áûòü äîñòóïíà âñåì âðà÷àì â ñïá, êîãäà âàø ðåáåíîê åùå ïîä ñòîë ïåøêîì õîäèë
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#27
|
||||
|
||||
Ñêîëüêî äíåé áóäåò äîñòàòî÷íî? Ïðîñòî ïðîïèâ öåôèêñèì 400ìã 5 äíåé ïî îäíîé òàáëåòêå, ïî÷åìó òî ñèìïòîìû âåðíóëèñü ÷åðåç íåñêîëüêî äíåé.. Õîòÿ ñíà÷àëà îíè ñòàëè ïðîïàäàòü. Ïî÷åìó òàê ïðîèçîøëî? Íå òà äîçèðîâêà? Èëè äíåé íåäîñòàòî÷íî ïèëè?
|
#28
|
||||
|
||||
ëå÷åíèå- â çàâèñèìîñòè îò êëèíèêè .Àíãèíà ñòðåïòîêîêêîâàÿ ïîòâåðæäàåòñÿ ïîëîæèòåëüíûì ñòðåïòîòåñòîì áûñòðûì èëè âûñåâîì ñòðåïòîêîêêà, âçÿòûì äî íà÷àëà ëå÷åíèÿ ÀÁ, èç çåâà,à íå àíàëèçîì êðîâè.Åñëè åñòü ÷åòêèå êëèíè÷åñêèå äàííûå ñòðåïòîêîêêîâîé àíãèíû/ òîíçèëèòà- ëå÷åíèå ïåíèöèëëèíàìè/ öåôàëîñïîðèíàìè 10 äíåé...Åñëè ëå÷èëè 2-é ðàç ïðîñòî àíàëèç êðîâè- è 5 äíåé àìîêñèêëàâà äîñòàòî÷íî ïðè îòñóòñâèè êëèíèêè ñåé÷àñ
|
#29
|
||||
|
||||
Òåñò ñäàâàëè íà ñòðåïòîêîêê, â ïîëèêëèíèêå îòâåò îòðèöàòåëüíûé, ñàìè ïîêóïàëè ñòðåïòîòåñò, äî ïðèìåíåíèÿ àíòèáèîòèêà äåëàëè, òîæå îòðèöàòåëüíûé. Íå ïîíÿòíî ïî÷åìó ñèìïòîìû âåðíóëèñü ñíîâà, ïîñëå 5 äíåé ïðè¸ìà àíòèáèîòèêà...
|
#30
|
||||
|
||||
âîçìîæíî íàëîæåíèe íîâîé èíôåêöèè.Ïðè îòñóòñâèè äàííûõ çà ñòðåï.ôàðèíãèò ( ïîëîæ.òåñò) 5 äíåâíîãî êóðñà àìîêñèêëàâà ìîæåò áûòü äîñòàòî÷íî
|